The Centre for Reproductive and Genetic Health, University College Hospital, 256 Gray's Inn Road, London WC1X 8LD, United Kingdom.
Reprod Biomed Online. 2012 Sep;25(3):273-7. doi: 10.1016/j.rbmo.2012.05.003. Epub 2012 May 23.
High-resolution transvaginal ultrasound has facilitated the diagnosis of adenomyosis. This study determined the prevalence of this finding in infertile women and its effect on the outcome of IVF/intracytoplasmic sperm injection (ICSI). This prospective study evaluated 275 consecutive women, commencing IVF/ICSI for the first time. Inclusion criteria were adequate ovarian reserve. Women with fibroids or a previous myomectomy were excluded. All women were screened for adenomyosis by transvaginal ultrasound on three separate occasions. The control group included 256 women and the adenomyosis group included 19 women. There was no significant difference in the ages of women, FSH, cause of infertility, body mass index, total dose of gonadotrophin used and number of oocytes collected between the two groups. However, women with adenomyosis had a higher mean antral follicle count (P=0.006). The clinical pregnancy rate (22.2% versus 47.2%) and ongoing pregnancy rate (11.1% versus 45.9%) were significantly lower in women with adenomyosis and the miscarriage rate (50.0% versus 2.8%) was significantly higher in women with adenomyosis (all P<0.001). Ultrasound evidence of adenomyosis is found in a significant number of women presenting with infertility and has a negative impact on the outcome of IVF/ICSI. This paper suggests that a common condition known as adenomyosis is associated with a reduced success following fertility treatment such as IVF. The diagnosis of adenomyosis has been greatly facilitated by the advent of high-resolution transvaginal ultrasound. This was a study including 275 consecutive women who were commencing IVF for the first time. Comparing women who did not have adenomyosis and those that did, the clinical and ongoing pregnancy rates were both lower in women with adenomyosis (22.2% versus 47.2% and 11.1% versus 45.9%, respectively). So, fewer women with adenomyosis became pregnant and had an ongoing pregnancy. The miscarriage rate was higher in women with adenomyosis compared with those without (50.0% versus 2.8%). We conclude that ultrasound evidence of adenomyosis is found in a significant number of women presenting with infertility and has a negative impact on the outcome of IVF.
经阴道高分辨率超声有助于诊断子宫腺肌病。本研究旨在确定该发现在不孕女性中的患病率及其对体外受精/卵胞浆内单精子注射(ICSI)结局的影响。这项前瞻性研究评估了 275 名首次接受体外受精/ICSI 的连续女性。纳入标准为卵巢储备功能充足。患有肌瘤或既往子宫肌瘤切除术的女性被排除在外。所有女性均通过经阴道超声在三个不同时间点筛查子宫腺肌病。对照组包括 256 名女性,子宫腺肌病组包括 19 名女性。两组女性的年龄、FSH、不孕原因、体重指数、使用的促性腺激素总剂量和采集的卵母细胞数量无显著差异。然而,患有子宫腺肌病的女性的平均窦卵泡计数较高(P=0.006)。患有子宫腺肌病的女性的临床妊娠率(22.2%比 47.2%)和持续妊娠率(11.1%比 45.9%)显著较低,而流产率(50.0%比 2.8%)显著较高(均 P<0.001)。患有子宫腺肌病的不孕女性中发现了大量超声证据,这对体外受精/ICSI 的结局有负面影响。本文表明,一种被称为子宫腺肌病的常见疾病与体外受精等生育治疗后的成功率降低有关。经阴道高分辨率超声的出现极大地方便了子宫腺肌病的诊断。这是一项包括 275 名首次接受体外受精的连续女性的研究。比较无子宫腺肌病和有子宫腺肌病的女性,患有子宫腺肌病的女性的临床和持续妊娠率均较低(分别为 22.2%比 47.2%和 11.1%比 45.9%)。因此,患有子宫腺肌病的女性怀孕和持续妊娠的人数较少。患有子宫腺肌病的女性的流产率高于无子宫腺肌病的女性(50.0%比 2.8%)。我们得出结论,经阴道超声证据表明,在大量不孕女性中存在子宫腺肌病,这对体外受精的结局有负面影响。